 鲜花( 85)  鸡蛋( 2)
|

楼主 |
发表于 2015-2-28 21:48
|
显示全部楼层
Stock soars after Cold-fX wins crucial approval3 S. h2 l8 p# C2 \9 ]0 ~$ t" X
0 l5 X4 Z3 `6 R. ]" j6 PEDMONTON - CV Technologies Inc. shares rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.! s7 Y6 I& T" y! e7 O' @
# I/ O( C6 B- {$ y/ t. m: oBY THE EDMONTON JOURNAL FEBRUARY 16, 2007
$ [' I9 ^/ [/ z8 y& i. N 1 ~/ c7 z% w5 q# ?; t. j
6 o/ @, f, L# x5 R, r% Z& LEDMONTON - CV Technologies Inc. SHARES rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.
! F4 A/ u' ~& K% I6 I, b% Q7 G! D3 Q4 A/ v W8 g
The agency said CV Technologies can continue to market Cold-fX as helping "to reduce the frequency, severity and duration of cold and flu symptoms by boosting the IMMUNE SYSTEM."
0 U( B4 T7 u# {$ B
9 u; A. F0 d- \4 Z- Q3 HThe APPROVAL follows a review of seven clinical trials and more than 10 years of research about the product.( u6 |4 c) ^% w l9 B
3 `, c1 l7 S2 v% `' L6 B
It should create even more confidence among consumers and medical professionals that the product works, CEO Jacqueline Shan said Thursday.2 ^4 w5 C; b$ L9 H1 X' c
, x8 C7 z; j! C: RIt certainly instilled confidence in the market, as shares closed at $2.90 on THE TORONTO STOCK EXCHANGE, up $1.08 on a volume of 4.6 million.: Z5 U0 v% n# l* {
, [& K5 a; h; Q: Z. i% u0 B$ k
"As a scientist, it's one of the highlights of my CAREER," Shan said.& }* w* w2 _: K2 k0 L
% i9 s- W% i% e
"This approval is a breakthrough in realizing our vision of being a global leader in developing products for disease prevention."
+ y4 r% v3 \) w, w1 {0 o ~ E, B
It's Cold-fX's strongest medical recognition to date, said Shan. It means the company can advertise the HEALTH BENEFITS more effectively to consumers and health professionals, she said.
9 {1 S! L+ p1 t& ]+ h& ^8 E ]: d3 X; j0 V+ s
Ginseng-based Cold-fX is already the top-selling cold and flu treatment in Canada, but Shan said there is plenty of room for more growth.3 o6 a* H; j. u9 I& p# J( Z8 E5 L
$ s9 {) x; C' QThe approval will also help raise the product's PROFILE in the lucrative U.S. market, which Cold-fX entered in October. The move came with a new marketing push, using former Oilers superstar Mark Messier as its spokesman.2 Z4 Z9 V. M }/ \
, D5 _; Q- e, N
9 ^7 |7 x9 }: q3 ]# g
http://www.canada.com/story.html ... 9-be80-f40f1426f662 |
|